Analysts Offer Insights on Healthcare Companies: Beta Bionics, Inc. (BBNX), Medline, Inc. Class A (MDLN) and Palatin Technologies (PTN)
There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Beta Bionics, Inc. (BBNX – Research Report), Medline, Inc. Class A (MDLN – Research Report) and Palatin Technologies (PTN – Research Report) with bullish sentiments.
President's Day Sale - 70% Off
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Beta Bionics, Inc. (BBNX)
In a report released today, Matthew O’Brien from Piper Sandler maintained a Buy rating on Beta Bionics, Inc., with a price target of $32.00. The company’s shares closed last Tuesday at $13.97.
According to TipRanks.com, O’Brien is ranked 0 out of 5 stars with an average return of
Currently, the analyst consensus on Beta Bionics, Inc. is a Moderate Buy with an average price target of $26.67, representing a 91.9% upside. In a report issued on February 9, UBS also initiated coverage with a Buy rating on the stock with a $24.00 price target.
See Insiders’ Hot Stocks on TipRanks >>
Medline, Inc. Class A (MDLN)
In a report released today, Jason Bednar from Piper Sandler maintained a Buy rating on Medline, Inc. Class A, with a price target of $50.00. The company’s shares closed last Tuesday at $46.16, close to its 52-week high of $47.99.
According to TipRanks.com, Bednar has currently 0 stars on a ranking scale of 0-5 stars, with an average return of
Medline, Inc. Class A has an analyst consensus of Strong Buy, with a price target consensus of $47.54, representing a 6.7% upside. In a report issued on February 5, Tigress Financial also initiated coverage with a Buy rating on the stock with a $55.00 price target.
Palatin Technologies (PTN)
Alliance Global Partners analyst Scott Henry reiterated a Buy rating on Palatin Technologies today and set a price target of $50.00. The company’s shares closed last Tuesday at $17.59.
According to TipRanks.com, Henry is a 1-star analyst with an average return of
Currently, the analyst consensus on Palatin Technologies is a Moderate Buy with an average price target of $50.00.
